SEPARATION OF T-CELL-STIMULATING ACTIVITY FROM STREPTOCOCCAL M-PROTEIN

被引:45
作者
FLEISCHER, B [1 ]
SCHMIDT, KH [1 ]
GERLACH, D [1 ]
KOHLER, W [1 ]
机构
[1] INST MICROBIOL & EXPTL THERAPY,O-6900 JENA,GERMANY
关键词
D O I
10.1128/IAI.60.5.1767-1770.1992
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The superantigenic properties of M protein type 5 of Streptococcus pyogenes have been implicated as an important pathogenicity factor in streptococcal autoimmune diseases. Here we show that after a single purification step by affinity chromatography on immobilized albumin or fibrinogen, M protein has no mitogenic activity for T cells. We demonstrate that the superantigenicity of M proteins of type 5 and type 1 is due to contamination with the highly potent pyrogenic exotoxins of S. pyogenes in the range of 0.1 to 0.01%. These results raise a general caveat for work with these extremely active T-cell mitogens, because the mitogenicity of other streptococcal or staphylococcal proteins could be due to similar minute contamination with potent superantigens that are undetectable by any biochemical method but extremely effective in stimulating sensitive T cells.
引用
收藏
页码:1767 / 1770
页数:4
相关论文
共 21 条
[1]  
ABE J, 1991, J IMMUNOL, V146, P2447
[2]   PEPTIC DIGESTION OF STREPTOCOCCAL M PROTEIN .2. EXTRACTION OF M ANTIGEN FROM GROUP A STREPTOCOCCI WITH PEPSIN [J].
BEACHEY, EH ;
CAMPBELL, GL ;
OFEK, I .
INFECTION AND IMMUNITY, 1974, 9 (05) :891-896
[3]  
BEESEN D, 1989, J EXP MED, V169, P269
[4]   SIMPLE PROCEDURE FOR PRODUCTION BY GROUP C STREPTOCOCCI OF PHAGE-ASSOCIATED LYSIN ACTIVE AGAINST GROUP A STREPTOCOCCI [J].
COHEN, JO ;
GROSS, H ;
HARRELL, WK .
APPLIED MICROBIOLOGY, 1975, 29 (02) :175-178
[5]   STREPTOCOCCAL M-PROTEIN - MOLECULAR DESIGN AND BIOLOGICAL BEHAVIOR [J].
FISCHETTI, VA .
CLINICAL MICROBIOLOGY REVIEWS, 1989, 2 (03) :285-314
[6]  
FLEISCHER B, 1991, J IMMUNOL, V146, P11
[7]   BACTERIAL TOXINS AS PROBES FOR THE T-CELL ANTIGEN RECEPTOR [J].
FLEISCHER, B .
IMMUNOLOGY TODAY, 1989, 10 (08) :262-264
[8]  
FLEISCHER B, 1991, MED MICROBIOL IMMUN, V180, P273
[9]  
GERLACH D, 1987, ZBL BAKT-INT J MED M, V266, P347
[10]  
KANTOR FS, 1965, J EXP MED, V121, P848